Data as of Sep 18, 2026 · Based on 3,315,446 AI responses across 10,525 prompts · See how Parse measures this
10 of 11 measured questions
Science 37science37.comScience 37 is a modern clinical research site that delivers trials directly to patients' homes, enabling participation from anywhere. It markets itself as the first and only FDA-inspected direct-to-patient site and has supported over 200 trials across therapeutic areas, with Tufts CSDD validation of higher enrollment and faster timelines. The company provides patient- and site-centric enrollment solutions to expand access, enhance diversity, and optimize enrollment for sponsors and patients.
The market map · 5 of 97 labelled
Clinical Trial Operations Platforms →Where Science 37 ranks in AI
Excerpts where Science 37 appeared in the AI's answer
Science 37 is another important vendor if the home visit itself is central to your protocol rather than merely an optional decentralized feature.
Science 37 is probably my first choice if home health is a core part of the protocol.
Excerpts where Science 37 appeared in the AI's answer
Science 37 : Operating via an orchestration platform rather than a traditional modular software sale, Science 37’s proprietary technology natively unifies workflow management for remote patients and internal study staff.
Science 37 The Setup: Operates a unified operating system designed specifically for agile, hybrid, and completely virtual/remote trial management.
Excerpts where Science 37 appeared in the AI's answer
Science 37 is built explicitly for fully virtual and hybrid trials, shining particularly bright when your protocol relies heavily on remote workflows, telemedicine, and diverse wearable integrations.
Science 37 is built explicitly for fully virtual trials and heavy remote orchestration.
Excerpts where Science 37 appeared in the AI's answer
Science 37 : Specializes in decentralized clinical trial (DCT) infrastructure
